Question 1

What is Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?

Accepted Answer

Rhythm Pharmaceuticals, Inc. (RYTM) reported comprehensive income (loss), net of tax, attributable to parent of -$54.4M in Q1 2026.

Question 2

How has Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?

Accepted Answer

Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 7.0% year-over-year, from -$50.83M to -$54.4M.

Question 3

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?

Accepted Answer

Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 30.7% compound annual growth rate (CAGR), from -$69.53M to -$202.67M.

Question 4

What does comprehensive income (loss), net of tax, attributable to parent mean?

Accepted Answer

This metric represents the total change in equity from non-owner sources, including both net income and other comprehensive income items like foreign currency adjustments and unrealized gains on securities. It offers a more holistic view of the company's financial performance beyond traditional net income. Investors use this to assess the total impact of market and economic factors on the company's net worth.

Rhythm Pharmaceuticals, Inc. RYTM Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

Ask your AI about Rhythm Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent.

Questions, answered.